STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION (Tables)
|
12 Months Ended |
Mar. 31, 2016 |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
|
Schedule of assumptions used in calculating fair values |
The weighted-average fair values and the assumptions used in calculating fair values during each fiscal period are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended March 31, |
|
2016 |
|
2015 |
|
2014 |
Option life (in years) |
0.5 |
|
|
0.5 |
|
|
0.5 |
|
Risk-free interest rate |
0.26 |
% |
|
0.07 |
% |
|
0.07 |
% |
Stock price volatility |
77.94 |
% |
|
36.58 |
% |
|
43.71 |
% |
Weighted-average grant date fair value |
$ |
0.29 |
|
|
$ |
0.36 |
|
|
$ |
0.40 |
|
|
Summary of share-based compensation expense |
The following tables summarize share-based compensation expense (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended March 31, |
|
2016 |
|
2015 |
|
2014 |
Share-based compensation expense: |
|
|
|
|
|
Cost of revenue |
$ |
1,241 |
|
|
$ |
1,489 |
|
|
$ |
1,963 |
|
Research and development |
1,864 |
|
|
2,559 |
|
|
3,430 |
|
Sales and marketing |
2,907 |
|
|
3,506 |
|
|
4,097 |
|
General and administrative |
2,904 |
|
|
4,029 |
|
|
3,969 |
|
Total share-based compensation expense |
$ |
8,916 |
|
|
$ |
11,583 |
|
|
$ |
13,459 |
|
|
Schedule of share-based compensation by type of award |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended March 31, |
|
2016 |
|
2015 |
|
2014 |
Share-based compensation by type of award: |
|
|
|
|
|
Stock options |
$ |
2 |
|
|
$ |
617 |
|
|
$ |
826 |
|
Restricted stock |
8,220 |
|
|
10,102 |
|
|
11,356 |
|
Stock purchase plan |
694 |
|
|
864 |
|
|
1,277 |
|
Total share-based compensation expense |
$ |
8,916 |
|
|
$ |
11,583 |
|
|
$ |
13,459 |
|
|
Schedule of activity relating to stock option plans |
A summary of activity relating to all of our stock option plans is as follows (stock options and intrinsic value in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options |
|
Weighted-
Average
Exercise Price
|
|
Weighted-
Average
Remaining
Contractual Term
|
|
Aggregate
Intrinsic Value
|
Outstanding as of March 31, 2015 |
4,944 |
|
|
$ |
1.47 |
|
|
|
|
|
Exercised |
(294 |
) |
|
1.01 |
|
|
|
|
|
Forfeited |
(323 |
) |
|
1.00 |
|
|
|
|
|
Expired |
(196 |
) |
|
1.69 |
|
|
|
|
|
Outstanding as of March 31, 2016 |
4,131 |
|
|
$ |
1.52 |
|
|
0.84 |
|
$ |
1,646 |
|
Vested and expected to vest at March 31, 2016 |
4,131 |
|
|
$ |
1.52 |
|
|
0.84 |
|
$ |
1,646 |
|
Exercisable as of March 31, 2016 |
4,131 |
|
|
$ |
1.52 |
|
|
0.84 |
|
$ |
1,646 |
|
|
Summary of information about stock options outstanding and exercisable |
The following table summarizes information about stock options outstanding and exercisable as of March 31, 2016 (stock options in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range of Exercise Prices |
|
Stock Options
Outstanding
|
|
Weighted-
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual Life
(Years)
|
|
Stock Options
Exercisable
|
|
Weighted-
Average
Exercise
Price
|
$0.63 |
|
— |
|
$0.92 |
|
40 |
|
|
$ |
0.72 |
|
|
3.54 |
|
40 |
|
|
$ |
0.72 |
|
$0.98 |
|
— |
|
$1.23 |
|
2,651 |
|
|
0.99 |
|
|
0.24 |
|
2,651 |
|
|
0.99 |
|
$1.85 |
|
— |
|
$2.59 |
|
1,419 |
|
|
2.52 |
|
|
1.91 |
|
1,419 |
|
|
2.52 |
|
$2.90 |
|
— |
|
$2.93 |
|
21 |
|
|
2.91 |
|
|
0.94 |
|
21 |
|
|
2.91 |
|
|
|
|
|
|
|
4,131 |
|
|
|
|
|
|
4,131 |
|
|
|
|
|
Summary of activity relating to restricted stock |
A summary of activity relating to our restricted stock follows (shares in thousands):
|
|
|
|
|
|
|
|
|
Shares |
|
Weighted-Average
Grant Date
Fair Value
|
Nonvested as March 31, 2015 |
13,791 |
|
|
$ |
1.34 |
|
Granted |
6,854 |
|
|
1.61 |
|
Vested |
(6,426 |
) |
|
1.43 |
|
Forfeited |
(3,110 |
) |
|
1.54 |
|
Nonvested as March 31, 2016 |
11,109 |
|
|
$ |
1.39 |
|
|